Universe · entity

Ikarian Capital, LLC

Institutional manager (13F) · CIK 1778253
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $617M
#IssuerValueShares
1TERNS PHARMACEUTICALS INC$77M1,456,378
2KODIAK SCIENCES INC$48M1,265,795
3ALUMIS INC$27M1,213,548
4VAXCYTE INC$25M428,682
5PRAXIS PRECISION MEDICINES I$23M71,581
6HARROW INC$19M543,047
7RELMADA THERAPEUTICS INC$19M2,688,359
8CYTOKINETICS INC$19M283,572
9TENAX THERAPEUTICS INC$16M1,017,600
10CAPRICOR THERAPEUTICS INC$16M528,015
11REVOLUTION MEDICINES INC$16M163,142
12CELLDEX THERAPEUTICS INC NEW$15M461,247
13PHARVARIS N V$14M486,856
14CONNECT BIOPHARMA HLDGS LTD$13M5,388,486
15BRIGHT MINDS BIOSCIENCES INC$12M166,647
16BRIDGEBIO PHARMA INC$12M160,120
17ORUKA THERAPEUTICS INC$12M242,021
18ALTO NEUROSCIENCE INC$12M515,000
19SOLENO THERAPEUTICS INC$12M344,123
20MAZE THERAPEUTICS INC$11M378,999
21ANI PHARMACEUTICALS INC$11M147,085
22CONTINEUM THERAPEUTICS INC$11M807,874
23ULTRAGENYX PHARMACEUTICAL IN$10M482,571
24IONIS PHARMACEUTICALS INC$10M127,038
25OLEMA PHARMACEUTICALS INC$9M598,281
26EUPRAXIA PHARMACEUTICALS INC$9M1,214,741
27DAMORA THERAPEUTICS INC$9M335,710
28PALVELLA THERAPEUTICS INC NE$8M64,626
29FULCRUM THERAPEUTICS INC$8M1,049,161
30VERA THERAPEUTICS INC$8M200,000
31SPRUCE BIOSCIENCES INC$8M121,356
32INVENTIVA SA$8M1,429,101
33JADE BIOSCIENCES INC$7M512,349
34OCUGEN INC$7M3,962,972
35ZURA BIO LTD$7M1,193,492
36OVID THERAPEUTICS INC$6M2,894,704
37ABIVAX SA$6M57,635
38ELI LILLY & CO$6M6,547
39ALPHA COGNITION INC$6M1,056,259
40PELTHOS THERAPEUTICS INC$5M256,598
41SURROZEN INC$5M173,107
42TECTONIC THERAPEUTIC INC$5M157,537
43ALECTOR INC$4M2,082,606
44LEGEND BIOTECH CORP$4M226,888
45KARYOPHARM THERAPEUTICS INC$4M733,435
46LIPOCINE INC NEW$4M508,556
47DELCATH SYS INC$4M431,251
48ARVINAS INC$4M358,257
49COMPASS PATHWAYS PLC$4M675,000
50CARDIOL THERAPEUTICS INC$4M2,725,000
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.